Avricore Health (AVCRF) EBIAT (2016 - 2025)
Historic EBIAT for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to -$275535.6.
- Avricore Health's EBIAT fell 10996.78% to -$275535.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 161831.99%. This contributed to the annual value of -$488620.4 for FY2024, which is 598.34% up from last year.
- As of Q3 2025, Avricore Health's EBIAT stood at -$275535.6, which was down 10996.78% from -$331271.8 recorded in Q2 2025.
- Avricore Health's EBIAT's 5-year high stood at $211592.0 during Q2 2023, with a 5-year trough of -$1.0 million in Q4 2022.
- Moreover, its 5-year median value for EBIAT was -$146588.2 (2022), whereas its average is -$182499.1.
- Over the last 5 years, Avricore Health's EBIAT had its largest YoY gain of 18829.09% in 2024, and its largest YoY loss of 126540.48% in 2024.
- Avricore Health's EBIAT (Quarter) stood at -$165724.0 in 2021, then tumbled by 518.65% to -$1.0 million in 2022, then soared by 104.27% to $43766.6 in 2023, then plummeted by 1265.4% to -$510057.6 in 2024, then soared by 45.98% to -$275535.6 in 2025.
- Its EBIAT stands at -$275535.6 for Q3 2025, versus -$331271.8 for Q2 2025 and -$53914.9 for Q1 2025.